| Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer K Roszkowski, W Jozwicki, P Blaszczyk, A Mucha-Malecka, A Siomek Medical science monitor: international medical journal of experimental and …, 2011 | 116 | 2011 |
| Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity M Reinfuss, A Mucha-Małecka, T Walasek, P Blecharz, J Jakubowicz, ... Lung Cancer 71 (3), 344-349, 2011 | 80 | 2011 |
| Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer M Snietura, W Piglowski, M Jaworska, A Mucha-Malecka, G Wozniak, ... European Archives of Oto-Rhino-Laryngology 268, 721-726, 2011 | 39 | 2011 |
| Active HPV infection and its influence on survival in head and neck squamous-cell cancer A Janecka-Widła, A Mucha-Małecka, K Majchrzyk, K Halaszka, ... Journal of cancer research and clinical oncology 146, 1677-1692, 2020 | 34 | 2020 |
| Prognostic factors in patients with T1 glottic cancer treated with radiotherapy A Mucha-Małecka, A Chrostowska, K Urbanek, K Małecki Strahlentherapie und Onkologie 195 (9), 792, 2019 | 32 | 2019 |
| CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy A Adamczyk, JA Niemiec, A Ambicka, A Mucha-Małecka, J Mituś, J Ryś Journal of molecular histology 45, 35-45, 2014 | 31 | 2014 |
| Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal … JA Niemiec, A Adamczyk, A Ambicka, A Mucha-Malecka, WM Wysocki, ... Applied Immunohistochemistry & Molecular Morphology 22 (1), 10-16, 2014 | 29 | 2014 |
| Prognostic value of the interval from surgery to initiation of radiation therapy in correlation with some histo-clinical parameters in patients with malignant supratentorial … B Gliński, J Urbański, M Hetnał, K Małecki, M Jarosz, A Mucha-Małecka, ... Contemporary Oncology/Współczesna Onkologia 16 (1), 34-37, 2012 | 27 | 2012 |
| Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors T Skóra, J Nowak-Sadzikowska, A Mucha-Małecka, B Szyszka-Charewicz, ... European Archives of Oto-Rhino-Laryngology 272, 673-679, 2015 | 24 | 2015 |
| Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16 B Biesaga, A Mucha-Małecka, A Janecka-Widła, M Kołodziej-Rzepa, ... Journal of Cancer Research and Clinical Oncology 144, 63-73, 2018 | 20 | 2018 |
| EGFR/PI3K/Akt/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status A Janecka-Widła, K Majchrzyk, A Mucha-Małecka, B Biesaga Polish Journal of Pathology 72 (4), 296-314, 2021 | 17 | 2021 |
| Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer JA Niemiec, A Adamczyk, A Ambicka, A Mucha-Małecka, WM Wysocki, ... American journal of translational research 9 (3), 1435, 2017 | 16 | 2017 |
| HPV16 detection by qPCR method in relation to quantity and quality of DNA extracted from archival formalin fixed and paraffin embedded head and neck cancer tissues by three … B Biesaga, A Janecka, A Mucha-Małecka, A Adamczyk, S Szostek, ... Journal of Virological Methods 236, 157-163, 2016 | 16 | 2016 |
| Hematogenous metastases in patients with Stage I or II endometrial carcinoma P Blecharz, K Urbaski, A Mucha-maecka, K Maecki, M Reinfuss, ... Strahlentherapie und Onkologie 187 (12), 806, 2011 | 16 | 2011 |
| Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors A Mucha-Małecka, B Gliński, M Hetnał, M Jarosz, J Urbański, ... Reports of Practical Oncology and Radiotherapy 17 (3), 141-145, 2012 | 15 | 2012 |
| Repopulation of tumour cells during radiotherapy is doubled during treatment gaps R Taranawski, K Skladowski, A Swienrniaka, A Wygoda, A Mucha Computational and Mathematical Methods in Medicine 2 (4), 297-305, 2000 | 13 | 2000 |
| Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases A Adamczyk, J Niemiec, A Ambicka, A Mucha-Małecka, J Ryś, J Mituś, ... Biomarkers in medicine 10 (3), 219-228, 2016 | 12 | 2016 |
| High-dose radiotherapy alone for patients with T4-stage laryngeal cancer A Mucha-maecka, K Skadowski Strahlentherapie und Onkologie 189 (8), 632, 2013 | 12 | 2013 |
| Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment K Małecki, B Gliński, A Mucha-Małecka, J Ryś, A Kruczak, K Roszkowski, ... Reports of Practical Oncology & Radiotherapy 15 (4), 87-92, 2010 | 12 | 2010 |
| Lymphangiogenesis assessed using three methods is related to tumour grade, breast cancer subtype and expression of basal marker J Niemiec, A Adamczyk, A Ambicka, A Mucha-Małecka, W Wysocki, ... Polish Journal of Pathology 63 (3), 165-171, 2012 | 11 | 2012 |
